Circulating SASP factors
2 papers3 findings
Interventions
2Fisetin
downin reviews1
1 study
Fisetin
downin reviews1
Fisetin decreases circulating SASP factors.
“the flavonoid fisetin have reduced circulating SASP factors in early studies.”
Review
Clinical interventions in aging19 Sep 2026
Dasatinib + quercetin
downin reviews1
1 study
Dasatinib + quercetin
downin reviews1
Dasatinib + quercetin decreases circulating SASP factors.
“Combinations such as dasatinib plus quercetin and the flavonoid fisetin have reduced circulating SASP factors in early studies.”
Review
Clinical interventions in aging19 Sep 2026
Associations
1Age-related clinical traits and diseases
mixedin humans1
1 study
Age-related clinical traits and diseases
mixedin humans1
Circulating SASP factors are associated with age-related clinical traits and diseases in humans.
“When tracked in circulation, SASP factors associate with age-related clinical traits and diseases”
Review
Ageing research reviews14 Jul 2026
Latest
3 in 12 monthsClinical Interventions in Aging
Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review
ReviewMultimorbidity
Scientific Reports
Circulating senescence-associated secretory phenotype factors across the stages of type 1 diabetes in a cross-sectional cohort
Cross-sectional study in peopleType 1 diabetes
EBioMedicine
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Non-randomised trial in 9 peopleSenolytics